INSIGHTS ON CELL & GENE COMMERCIALIZATION ISSUES

• Gene Therapy Deals, Collaborations, & Partnerships With Astellas' Richard Wilson

  Astellas' Richard Wilson is Erin Harris' guest on Cell & Gene: The Podcast to discuss deals and collaborations in gene therapy. 

• Driving Down COGS: Leveraging Automation Technologies And Mitigating Risk

  The technologies aimed at automating and standardizing cell therapy production are poised to offer advanced therapy companies and CDMOs process-level improvements that streamline and accelerate workflows.

• A Multi-Vector Perspective: LVV And AAV Development And Manufacturing

  Finding a CDMO partner with the resources and expertise to achieve efficient and scalable manufacturing is a key step in achieving the scalable manufacture of safe, effective AAV gene therapies.

• 3 Steps For Cell & Gene Therapy Medical Affairs Teams To Provide Strategic Value

  Historically, medical affairs has been seen as more of a resource, as the group that answers complex scientific questions. However, medical affairs teams at cell and gene therapy companies must be more strategic.

• Driving Down COGS: Breaking Down Automated Manufacturing

  While working to optimize discrete process steps is important, achieving CAR-T scalability requires finding ways to perform some steps concurrently, necessitating a more holistic approach to innovation.

• Important Ethical Questions Concerning CGTs

  This is a summary of Alliance For Regenerative Medicine's panel discussion, "The Importance Of Ethics In Gene And Cell Therapy," from this year's Meeting On The Mesa.

• Inside 2023 Meeting On The Mesa With ARM's COO, Rita Johnson-Greene

  Hear from speakers on the Cell & Gene: The Podcast about Meeting on the Mesa 2023, the events new location for 2024, major topics and trends at this year's event, and ARM's GROW internship program.

• 5 Takeaways From Meeting On The Mesa 2023

  This year's conference delivered outstanding networking, presentations, and panel discussions with industry leaders. Here are 5 of my favorite quotes from this year's participants.

• Crafting An Effective Commercialization Strategy For CGTs

  Patient access and manufacturing efficiency persist as barriers to widespread adoption of CGTs. An effective commercialization strategy is crucial to expand access to these life-changing therapies.

• ARM’s 2023 Meeting On The Mesa: Data, Ethics, And More

  ARM's 2023 Meeting on the Mesa was chock full of informative sessions, impactful conversations, partnering opportunities, and peer networking. Here's a brief recap.